NASDAQ:INCY

Incyte Stock Predictions

Healthcare > Biotechnology

Buy INCY

*Your capital is at risk

$97.98

+5.74 (+6.22%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

INCY Prediction Chart

INCY Predictions History

Latest community submissions for INCY.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
NameNotImportant Pro	Apr 29, 2019	$73.65 -0.98%	$74.38	X	99.02%	1
NameNotImportant Pro	Apr 22, 2019	$73.61 -0.07%	$73.66	X	99.93%	10
Chaser Pro	Apr 3, 2019	$87.22 +3.40%	$84.35	X	96.60%	0
JS Pro	Jul 6, 2018	$70.07 -1.07%	$70.83	X	98.90%	1
Emilio.Tabja.24943	May 23, 2018	$59.12 -11.19%	$66.57	X	88.80%	0
JS Pro	May 22, 2018	$66.26 -0.45%	$66.56	X	99.50%	4
Emilio.Tabja.24943	May 22, 2018	$57.16 -14.12%	$66.56	X	85.90%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for INCY with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT INCYTE CORPORATION

Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as oncogenic drivers in various liquid and solid tumor types; and ICLUSIG, a kinase inhibitor to treat chr...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by